Application 078314
- Type
- ANDA
- Sponsor
- GLENMARK PHARMS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NAPROXEN SODIUM | NAPROXEN SODIUM | TABLET;ORAL | EQ 250MG BASE | No | No |
| 002 | NAPROXEN SODIUM | NAPROXEN SODIUM | TABLET;ORAL | EQ 500MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078314-001 | NAPROXEN SODIUM | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | |
| A078314-002 | NAPROXEN SODIUM | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078314-001 | AB |
| A078314-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A078314-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-27 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A078314-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-27 | bb7c543d1eb4… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A078314-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A078314-002 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A078314-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A078314-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078314-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078314-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A078314-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A078314-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078314-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078314-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078314-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078314-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078314-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078314-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078314-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078314-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078314-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078314-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078314-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078314-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A078314-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A078314-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078314-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078314-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078314-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078314-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A078314-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A078314-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A078314-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A078314-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078314-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078314-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A078314-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A078314-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A078314-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A078314-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A078314-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A078314-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A078314-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A078314-002 | AB | 1 | bb7c543d1eb4… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen Sodium | NAPROXEN SODIUM | Advanced Rx of Tennessee, LLC | 36996557-3227-b753-e063-6394a90a7b6f | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | 078314 ANDA078314 |
| Naproxen Sodium | NAPROXEN SODIUM | Bryant Ranch Prepack | 83dd8829-7ba0-4a8d-a979-41a5e077c49f | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | 078314 ANDA078314 |
| Naproxen Sodium | NAPROXEN SODIUM | Glenmark Pharmaceuticals Inc., USA | 6c5bb008-e66f-4ef0-bf84-aca7eb5983e9 | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | 078314 ANDA078314 68462-179 68462-178 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 10544-063 | Naproxen Sodium | Naproxen Sodium | Blenheim Pharmacal, Inc. | ANDA | Current |
| 10544-275 | Naproxen Sodium | Naproxen Sodium | Blenheim Pharmacal, Inc. | ANDA | Current |
| 10544-276 | Naproxen Sodium | Naproxen Sodium | Blenheim Pharmacal, Inc. | ANDA | Current |
| 45865-519 | Naproxen Sodium | Naproxen Sodium | Medsource Pharmaceuticals | ANDA | Current |
| 45865-519 | Naproxen Sodium | Naproxen Sodium | Medsource Pharmaceuticals | ANDA | Current |
| 55289-467 | Naproxen Sodium | Naproxen Sodium | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 61919-183 | ANAPROX | NAPROXEN SODIUM | DIRECT RX | ANDA | Current |
| 61919-183 | ANAPROX | NAPROXEN SODIUM | DIRECT RX | ANDA | Current |
| 63629-3638 | Naproxen Sodium | Naproxen Sodium | Bryant Ranch Prepack | ANDA | Current |
| 63629-3638 | Naproxen Sodium | Naproxen Sodium | Bryant Ranch Prepack | ANDA | Current |
| 63874-339 | Naproxen Sodium | Naproxen Sodium | Altura Pharmaceuticals, Inc. | ANDA | Current |
| 63874-489 | Naproxen Sodium | Naproxen Sodium | Altura Pharmaceuticals, Inc. | ANDA | Current |
| 68071-3054 | Naproxen Sodium | Naproxen Sodium | NuCare Pharmaceuticals, Inc. | ANDA | Current |
| 68462-178 | Naproxen Sodium | Naproxen Sodium | Glenmark Pharmaceuticals Limited Inc., USA | ANDA | Current |
| 68462-178 | Naproxen Sodium | Naproxen Sodium | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-178 | Naproxen Sodium | Naproxen Sodium | Glenmark Pharmaceuticals Limited Inc., USA | ANDA | Current |
| 68462-178 | Naproxen Sodium | Naproxen Sodium | Glenmark Pharmaceuticals Limited Inc., USA | ANDA | Current |
| 68462-178 | Naproxen Sodium | Naproxen Sodium | Glenmark Pharmaceuticals Limited Inc., USA | ANDA | Current |
| 68462-179 | Naproxen Sodium | Naproxen Sodium | Glenmark Pharmaceuticals Limited Inc., USA | ANDA | Current |
| 68462-179 | Naproxen Sodium | Naproxen Sodium | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-179 | Naproxen Sodium | Naproxen Sodium | Glenmark Pharmaceuticals Limited Inc., USA | ANDA | Current |
| 68462-179 | Naproxen Sodium | Naproxen Sodium | Glenmark Pharmaceuticals Limited Inc., USA | ANDA | Current |
| 68462-179 | Naproxen Sodium | Naproxen Sodium | Glenmark Pharmaceuticals Limited Inc., USA | ANDA | Current |
| 68788-6934 | Naproxen Sodium | Naproxen Sodium | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-6934 | Naproxen Sodium | Naproxen Sodium | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-6934 | Naproxen Sodium | Naproxen Sodium | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 70518-0409 | Naproxen Sodium | Naproxen Sodium | REMEDYREPACK INC. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 23901 | ORIG | 2007-05-08 |